[1. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409(6818):307-12. DOI: 10.1038/3505300010.1038/3505300011201732]Search in Google Scholar
[2. Wang H, Chu WS, Hemphill C, Elbein SC. Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J Clin Endocrinol Metab. 2002;87(6):2520-4. DOI: 10.1210/jcem.87.6.8528 DOI: 10.1210/ jc.87.6.252010.1210/jcem.87.6.852812050208]Search in Google Scholar
[3. Adeghate E. An update on the biology and physiology of resistin. Cell Mol Life Sci. 2004;61(19-20):2485-96. DOI: 10.1007/s00018-004-4083-210.1007/s00018-004-4083-215526156]Search in Google Scholar
[4. Stumvoll M, Haring H. Resistin and adiponectin--of mice and men. Obes Res. 2002;10(11):1197-9. DOI: 10.1038/oby.2002.16210.1038/oby.2002.16212429885]Search in Google Scholar
[5. Vendrell J, Broch M, Vilarrasa N, Molina A, Gomez JM, Gutierrez C, et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res. 2004;12(6):962-71. DOI: 10.1038/ oby.2004.11810.1038/oby.2004.11815229336]Search in Google Scholar
[6. Milan G, Granzotto M, Scarda A, Calcagno A, Pagano C, Federspil G, et al. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes Res. 2002;10(11):1095-103. DOI: 10.1038/ oby.2002.14910.1038/oby.2002.14912429872]Search in Google Scholar
[7. Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun. 2005;334(4):1092-101. DOI: 10.1016/j.bbrc.2005.06.20210.1016/j.bbrc.2005.06.20216039994]Search in Google Scholar
[8. Barnes KM, Miner JL. Role of resistin in insulin sensitivity in rodents and humans. Curr Prot Peptide Sci. 2009;10(1):96-107. DOI: 10.2174/13892030978731523910.2174/13892030978731523919275676]Search in Google Scholar
[9. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun. 2003;309(2):286-90. DOI: 10.1016/j.bbrc.2003.07.00310.1016/j.bbrc.2003.07.00312951047]Search in Google Scholar
[10. Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation. 2003;108(6):736-40. DOI: 10.1161/01. CIR.0000084503.91330.49]Search in Google Scholar
[11. Steppan CM, Lazar MA. The current biology of resistin. J Intern Med. 2004;255(4):439-47. DOI: 10.1111/j.1365-2796.2004.01306.x10.1111/j.1365-2796.2004.01306.x15049878]Search in Google Scholar
[12. Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A, et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res. 2003;11(8):997-1001. DOI: 10.1038/oby.2003.13710.1038/oby.2003.13712917505]Search in Google Scholar
[13. de Luis DA, Gonzalez Sagrado M, Conde R, Aller R, Izaola O, Perez Castrillon JL, et al. Relation of resistin levels with cardiovascular risk factors and insulin resistance in non-diabetes obese patients. Diabetes Res Clin Prac. 2009;84(2):174-8. DOI: 10.1016/j.diabres. 2009.01.017]Search in Google Scholar
[14. Pfutzner A, Langenfeld M, Kunt T, Lobig M, Forst T. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin Lab. 2003;49(11-12):571-6.]Search in Google Scholar
[15. Iqbal N, Seshadri P, Stern L, Loh J, Kundu S, Jafar T, et al. Serum resistin is not associated with obesity or insulin resistance in humans. Eur Rev Med Pharmacol Sci. 2005;9(3):161-5.]Search in Google Scholar
[16. Chen CC, Li TC, Li CI, Liu CS, Wang HJ, Lin CC. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters. Metabolism. 2005;54(4):471-5. DOI: 10.1016/j.metabol. 2004.10.015]Search in Google Scholar
[17. Pischon T, Bamberger CM, Kratzsch J, Zyriax BC, Algenstaedt P, Boeing H, et al. Association of plasma resistin levels with coronary heart disease in women. Obes Res. 2005;13(10):1764-71. DOI: 10.1038/ oby.2005.21510.1038/oby.2005.21516286524]Search in Google Scholar
[18. Chen C, Jiang J, Lu JM, Chai H, Wang X, Lin PH, et al. Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am J Physiol Hear Cir Physiol. 2010;299(1):H193-201. DOI: 10.1152/ ajpheart.00431.200910.1152/ajpheart.00431.2009290413820435848]Search in Google Scholar
[19. Kougias P, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Adipocyte-derived cytokine resistin causes endothelial dysfunction of porcine coronary arteries. J Vasc Surg. 2005;41(4):691-8. DOI: 10.1016/j. jvs.2004.12.046]Search in Google Scholar
[20. Burnett MS, Lee CW, Kinnaird TD, Stabile E, Durrani S, Dullum MK, et al. The potential role of resistin in atherogenesis. Atherosclerosis. 2005;182(2):241-8. DOI: 10.1016/j.atherosclerosis.2005.02.01410.1016/j.atherosclerosis.2005.02.01416159596]Search in Google Scholar
[21. Xu W, Yu L, Zhou W, Luo M. Resistin increases lipid accumulation and CD36 expression in human macrophages. Biochem Biophys Res Commun. 2006;351(2):376-82. DOI: 10.1016/j.bbrc.2006.10.05110.1016/j.bbrc.2006.10.05117067553]Search in Google Scholar
[22. Rizkalla J, Melone M, Zhao A, Rashid S. The pathophysiological role of resistin in impaired lipoprotein metabolism in obesity. Circulation. 2009;120:S529.]Search in Google Scholar
[23. Calabro P, Samudio I, Willerson JT, Yeh ET. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation. 2004;110(21):3335-40. DOI: 10.1161/01. CIR.0000147825.97879.E7]Search in Google Scholar
[24. Cohen G, Horl WH. Resistin as a cardiovascular and atherosclerotic risk factor and uremic toxin. Semin Dial. 2009;22(4):373-7. DOI: 10.1111/j.1525-139X.2009.00583.x10.1111/j.1525-139X.2009.00583.x19708984]Search in Google Scholar
[25. Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y, et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun. 2004;314(2):415-9. DOI: 10.1016/j.bbrc.2003.12.10410.1016/j.bbrc.2003.12.10414733921]Search in Google Scholar
[26. Sharma R, Kumar C, Gangwani S, Singh Sugga G, Rana AC. Resistin and cardiovascular disorder. Afr J of Pharm Pharmacol. 2011;5(1):5.10.1111/j.2042-7158.1986.tb14234.x]Search in Google Scholar
[27. Lee TS, Lin CY, Tsai JY, Wu YL, Su KH, Lu KY, et al. Resistin increases lipid accumulation by affecting class A scavenger receptor, CD36 and ATP-binding cassette transporter-A1 in macrophages. Life Sci. 2009;84(3-4):97-104. DOI: 10.1016/j.lfs.2008.11.00410.1016/j.lfs.2008.11.00419041881]Search in Google Scholar
[28. Li L, Han JL, Mao JM, Guo LJ, Gao W. Association between serum resistin level and cardiovascular events in postmenopausal women with acute coronary syndrome undergoing percutaneous coronary intervention. Clin Med J. 2013;126(6):1058-62.]Search in Google Scholar
[29. Erer HB, Sayar N, Guvenc TS, Aksaray S, Yilmaz H, Altay S, et al. Prognostic value of serum resistin levels in patients with acute coronary syndrome. Kardiol Pol. 2014;72(2):181-6. DOI: 10.5603/KP.a2013.008610.5603/KP.a2013.008623633273]Search in Google Scholar
[30. Rosner B. Fundamentals of biostatistics. 5th ed. Pacific Grove, CA: Duxbury; 2000.]Search in Google Scholar
[31. Zhang MH, Na B, Schiller NB, Whooley MA. Association of resistin with heart failure and mortality in patients with stable coronary heart disease: data from the heart and Soul study. J Card Fail. 2011;17(1):24-30. DOI: 10.1016/j.cardfail.2010.08.00710.1016/j.cardfail.2010.08.00721187261]Search in Google Scholar
[32. Anfossi G, Russo I, Doronzo G, Pomero A, Trovati M. Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells. Mediators of inflammation. 2010;2010:174341. DOI: 10.1155/2010/17434110.1155/2010/174341290591120652043]Search in Google Scholar
[33. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive- leptin concentrations in normal-weight and obese humans. N Engl J of Med. 1996;334(5):292-5. DOI: 10.1056/NEJM19960201334050310.1056/NEJM1996020133405038532024]Search in Google Scholar
[34. Piemonti L, Calori G, Mercalli A, Lattuada G, Monti P, Garancini MP, et al. Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. Diabetes care. 2003;26(10):2883-9. DOI: 10.2337/diacare.26.10.288310.2337/diacare.26.10.288314514596]Search in Google Scholar
[35. Scholze A, Rattensperger D, Zidek W, Tepel M. Low serum leptin predicts mortality in patients with chronic kidney disease stage 5. Obesity (Silver Spring). 2007;15(6):1617-22. DOI: 10.1038/oby.2007.19110.1038/oby.2007.19117558000]Search in Google Scholar
[36. Sattar N, Wannamethee G, Sarwar N, Chernova J, Lawlor DA, Kelly A, et al. Leptin and coronary heart disease: prospective study and systematic review J Am Coll Cardiol. 2009;53(2):167-75. DOI: 10.1016/j. jacc.2008.09.035]Search in Google Scholar
[37. Ku IA, Farzaneh-Far R, Vittinghoff E, Zhang MH, Na B, Whooley MA. Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study. Atherosclerosis. 2011;217(2):503-8. DOI: 10.1016/j. atherosclerosis.2010.10.047]Search in Google Scholar
[38. Owens CD, Kim JM, Hevelone ND, Hamdan A, Raffetto JD, Creager MA, et al. Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein. J Vasc Surg. 2010;51(5):1152-9. DOI: 10.1016/j.jvs.2009.12.05110.1016/j.jvs.2009.12.051286067320223619]Search in Google Scholar
[39. Osawa H, Doi Y, Makino H, Ninomiya T, Yonemoto K, Kawamura R, et al. Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: the Hisayama Study. Cardiovasc Diabetol. 2009;8:60. DOI: 10.1186/1475-2840-8-6010.1186/1475-2840-8-60279044119922611]Search in Google Scholar
[40. Rajpathak SN, Kaplan RC, Wassertheil-Smoller S, Cushman M, Rohan TE, McGinn AP, et al. Resistin, but not adiponectin and leptin, is associated with the risk of ischemic stroke among postmenopausal women: results from the Women’s Health Initiative. Stroke. 2011;42(7):1813-20. DOI: 10.1161/STROKEAHA. 110.607853]Search in Google Scholar
[41. Zhang MH, Na B, Schiller NB, Whooley MA. Resistin, exercise capacity, and inducible ischemia in patients with stable coronary heart disease: data from the Heart and Soul study. Atherosclerosis. 2010;213(2):604-10. DOI: 10.1016/j.atherosclerosis.2010.09.01510.1016/j.atherosclerosis.2010.09.01520951381]Search in Google Scholar
[42. Krecki R, Krzeminska-Pakula M, Peruga JZ, Szczesniak P, Lipiec P, Wierzbowska-Drabik K, et al. Elevated resistin opposed to adiponectin or angiogenin plasma levels as a strong, independent predictive factor for the occurrence of major adverse cardiac and cerebrovascular events in patients with stable multivessel coronary artery disease over 1-year follow-up. Med Sci Monit. 2011;17(1):CR26-32. DOI: 10.12659/MSM.88132510.12659/MSM.881325352468121169907]Search in Google Scholar
[43. Lubos E, Messow CM, Schnabel R, Rupprecht HJ, Espinola-Klein C, Bickel C, et al. Resistin, acute coronary syndrome and prognosis results from the Athero- Gene study. Atherosclerosis. 2007;193(1):121-8. DOI: 10.1016/j.atherosclerosis.2006.05.03910.1016/j.atherosclerosis.2006.05.03916814296]Search in Google Scholar
[44. Lee SH, Ha JW, Kim JS, Choi EY, Park S, Kang SM, et al. Plasma adiponectin and resistin levels as predictors of mortality in patients with acute myocardial infarction: data from infarction prognosis study registry. Coron Artery Dis. 2009;20(1):33-9. DOI: 10.1097/ MCA.0b013e328318ecb010.1097/MCA.0b013e328318ecb018997620]Search in Google Scholar
[45. Efstathiou SP, Tsiakou AG, Tsioulos DI, Panagiotou TN, Pefanis AV, Achimastos AD, et al. Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke. Clin Chim Acta. 2007;378(1-2):78-85. DOI: 10.1016/j.cca.2006.10.02310.1016/j.cca.2006.10.02317173885]Search in Google Scholar
[46. Pilz S, Weihrauch G, Seelhorst U, Wellnitz B, Winkelmann BR, Boehm BO, et al. Implications of resistin plasma levels in subjects undergoing coronary angiography. Clin Endocrinol. 2007;66(3):380-6. DOI: 10.1111/j.1365-2265.2007.02743.x10.1111/j.1365-2265.2007.02743.x17302872]Search in Google Scholar
[47. Hoefle G, Saely CH, Risch L, Koch L, Schmid F, Rein P, et al. Relationship between the adipose-tissue hormone resistin and coronary artery disease. Clin Chim Acta. 2007;386(1-2):1-6. DOI: 10.1016/j.cca.2007.07.00110.1016/j.cca.2007.07.00117706624]Search in Google Scholar
[48. Luc G, Empana JP, Morange P, Juhan-Vague I, Arveiler D, Ferrieres J, et al. Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study. Int J Obes (Lond). 2010;34(1):118-26. DOI: 10.1038/ijo.2009.20410.1038/ijo.2009.20419823188]Search in Google Scholar
[49. Lim S, Koo BK, Cho SW, Kihara S, Funahashi T, Cho YM, et al. Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: the Korean atherosclerosis study (KAS): a 42-month prospective study. Atherosclerosis. 2008;196(1):398-404. DOI: 10.1016/j.atherosclerosis. 2006.11.017 ]Search in Google Scholar